79 filings
Page 3 of 4
8-K
9vm pj0xgbjol7qe0
15 Apr 20
Termination of a Material Definitive Agreement
4:00pm
8-K
g1d ppeom
27 Feb 20
Tocagen Reports Fourth Quarter and Full Year 2019 Financial Results
4:57pm
8-K
4lqfac5g1f
21 Feb 20
Departure of Directors or Certain Officers
12:00am
8-K
fnvi6tn
20 Feb 20
Entry into a Material Definitive Agreement
5:29pm
8-K
4xzkdcbl7e2m
19 Feb 20
Tocagen and Forte Biosciences Announce Merger
9:41pm
8-K
fqenwd
20 Dec 19
Entry into a Material Definitive Agreement
4:00pm
8-K
dgv4vx
22 Nov 19
Regulation FD Disclosure
4:57pm
8-K
ewar5bymfl1 9ad
12 Nov 19
Tocagen Reports Third Quarter 2019 Financial Results and Business Updates
4:00pm
8-K
d93vc7 2lbe
1 Nov 19
Entry into a Material Definitive Agreement
4:15pm
8-K
4v9nml f0r
3 Oct 19
Tocagen Announces Restructuring to Focus on Clinical Development
6:02am
8-K
y5ih8 hckzvas
8 Aug 19
Tocagen Reports Second Quarter 2019 Financial Results and Business Updates
4:52pm
8-K
npu47ijq7li 7p43
31 May 19
Submission of Matters to a Vote of Security Holders
4:05pm
8-K
udm6 083801qm
7 May 19
Tocagen Reports First Quarter 2019 Financial and Business Results
4:27pm
8-K
5lygx0 7xlx
16 Apr 19
Departure of Directors or Certain Officers
4:05pm
8-K
yxjhcy2q ki25lv
12 Apr 19
Departure of Directors or Certain Officers
4:02pm
8-K
eb999325t6
27 Feb 19
Tocagen Reports Fourth Quarter and Full Year 2018 Financial and Business Results
4:20pm
8-K
d5gqwi
15 Feb 19
Departure of Directors or Certain Officers
4:05pm
8-K
d15fggbgous6g m2aqb
13 Dec 18
Tocagen Announces Proposed Public Offering of Common Stock
4:09pm
8-K
h55c4x52cp sk333kw
12 Dec 18
Other Events
6:06am
8-K
000kzp0xj
21 Nov 18
Entry into a Material Definitive Agreement
4:37pm